LWM
LLY icon

LeConte Wealth Management’s Eli Lilly LLY Stock Holding History

LeConte Wealth Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$767K Buy
834
+41
+5% +$41.6K 0.5% 38
2025
Q4 		$852K Sell
793
-71
-8% -$67.9K 0.56% 30
2025
Q3 		$659K Buy
864
+291
+51% +$217K 0.44% 34
2025
Q2 		$447K Buy
573
+143
+33% +$111K 0.3% 44
2025
Q1 		$355K Buy
+430
New +$358K 0.23% 36

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

LeConte Wealth Management's LLY Position: Q1 2026 in Review

LeConte Wealth Management increased its Eli Lilly (LLY) stake by 5.2% in Q1 2026, buying an estimated $41.6K and bringing the position to 834 shares worth $767K. The position accounts for 0.5% of the portfolio, ranked #38.

LeConte Wealth Management first reported a position in LLY in Q1 2025 and has held it in 5 quarters since. The position peaked at $852K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • LeConte Wealth Management held 834 shares of Eli Lilly worth $767K as of Q1 2026.
  • LeConte Wealth Management bought 41 Eli Lilly shares in Q1 2026, an estimated $41.6K.
  • Eli Lilly made up 0.5% of LeConte Wealth Management's portfolio in Q1 2026, its #38 holding.
  • LeConte Wealth Management first reported a position in Eli Lilly in Q1 2025 and has held it in 5 quarters since.
  • LeConte Wealth Management's Eli Lilly position peaked at $852K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on LeConte Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.